201 related articles for article (PubMed ID: 32563247)
1. Pioglitazone for primary stroke prevention in Asian patients with type 2 diabetes and cardiovascular risk factors: a retrospective study.
Hung YC; Chiu LT; Huang HY; Bau DT
Cardiovasc Diabetol; 2020 Jun; 19(1):94. PubMed ID: 32563247
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study.
Liu CH; Lee TH; Lin YS; Sung PS; Wei YC; Li YR
Cardiovasc Diabetol; 2020 Jan; 19(1):2. PubMed ID: 31910836
[TBL] [Abstract][Full Text] [Related]
3. Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case-control study.
Woo MH; Lee HS; Kim J
Cardiovasc Diabetol; 2019 May; 18(1):67. PubMed ID: 31151454
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone use associated with reduced risk of the first attack of ischemic stroke in patients with newly onset type 2 diabetes: a nationwide nested case-control study.
Ha J; Choi DW; Kim KY; Nam CM; Kim E
Cardiovasc Diabetol; 2021 Jul; 20(1):152. PubMed ID: 34315501
[TBL] [Abstract][Full Text] [Related]
5. Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone.
Young LH; Viscoli CM; Schwartz GG; Inzucchi SE; Curtis JP; Gorman MJ; Furie KL; Conwit R; Spatz ES; Lovejoy A; Abbott JD; Jacoby DL; Kolansky DM; Ling FS; Pfau SE; Kernan WN;
Circulation; 2018 Sep; 138(12):1210-1220. PubMed ID: 29934374
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).
Yaghi S; Furie KL; Viscoli CM; Kamel H; Gorman M; Dearborn J; Young LH; Inzucchi SE; Lovejoy AM; Kasner SE; Conwit R; Kernan WN;
Circulation; 2018 Jan; 137(5):455-463. PubMed ID: 29084736
[TBL] [Abstract][Full Text] [Related]
7. Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study.
Yoo J; Jeon J; Baik M; Kim J
Cardiovasc Diabetol; 2023 May; 22(1):106. PubMed ID: 37147722
[TBL] [Abstract][Full Text] [Related]
8. The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety.
Leonard CE; Brensinger CM; Dawwas GK; Deo R; Bilker WB; Soprano SE; Dhopeshwarkar N; Flory JH; Bloomgarden ZT; Gagne JJ; Aquilante CL; Kimmel SE; Hennessy S
Cardiovasc Diabetol; 2020 Feb; 19(1):25. PubMed ID: 32098624
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes Mellitus.
Yen FS; Wang HC; Pan CW; Wei JC; Hsu CC; Hwu CM
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31544207
[TBL] [Abstract][Full Text] [Related]
10. Effects of Pioglitazone for Secondary Stroke Prevention in Patients with Impaired Glucose Tolerance and Newly Diagnosed Diabetes: The J-SPIRIT Study.
Tanaka R; Yamashiro K; Okuma Y; Shimura H; Nakamura S; Ueno Y; Tanaka Y; Miyamoto N; Tomizawa Y; Nakahara T; Furukawa Y; Watada H; Kawamori R; Hattori N; Urabe T
J Atheroscler Thromb; 2015; 22(12):1305-16. PubMed ID: 26269002
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Kernan WN; Viscoli CM; Furie KL; Young LH; Inzucchi SE; Gorman M; Guarino PD; Lovejoy AM; Peduzzi PN; Conwit R; Brass LM; Schwartz GG; Adams HP; Berger L; Carolei A; Clark W; Coull B; Ford GA; Kleindorfer D; O'Leary JR; Parsons MW; Ringleb P; Sen S; Spence JD; Tanne D; Wang D; Winder TR;
N Engl J Med; 2016 Apr; 374(14):1321-31. PubMed ID: 26886418
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes - A real-world population study in Taiwan.
Pai PY; Muo CH; Sung FC; Ho HC; Lee YT
Int J Cardiol; 2016 Jul; 215():114-9. PubMed ID: 27111172
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus.
Young LH; Viscoli CM; Curtis JP; Inzucchi SE; Schwartz GG; Lovejoy AM; Furie KL; Gorman MJ; Conwit R; Abbott JD; Jacoby DL; Kolansky DM; Pfau SE; Ling FS; Kernan WN;
Circulation; 2017 May; 135(20):1882-1893. PubMed ID: 28246237
[TBL] [Abstract][Full Text] [Related]
14. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone Use and Reduced Risk of Dementia in Patients With Diabetes Mellitus With a History of Ischemic Stroke.
Ha J; Choi DW; Kim KJ; Kim KY; Nam CM; Kim E
Neurology; 2023 Apr; 100(17):e1799-e1811. PubMed ID: 36792375
[TBL] [Abstract][Full Text] [Related]
16. GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease.
Yang YS; Chen HH; Huang CN; Hsu CY; Hu KC; Kao CH
Diabetes Care; 2022 May; 45(5):1184-1192. PubMed ID: 35275992
[TBL] [Abstract][Full Text] [Related]
17. Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.
Lu CJ; Sun Y; Muo CH; Chen RC; Chen PC; Hsu CY
Cerebrovasc Dis; 2013; 36(2):145-51. PubMed ID: 24029780
[TBL] [Abstract][Full Text] [Related]
18. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
[TBL] [Abstract][Full Text] [Related]
19. Detecting pioglitazone use and risk of cardiovascular events using electronic health record data in a large cohort of Chinese patients with type 2 diabetes.
Miao S; Dong X; Zhang X; Jing S; Zhang X; Xu T; Wang L; Du X; Xu H; Liu Y
J Diabetes; 2019 Aug; 11(8):684-689. PubMed ID: 30597747
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone Therapy and Fractures: Systematic Review and Meta- Analysis.
Pavlova V; Filipova E; Uzunova K; Kalinov K; Vekov T
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):502-507. PubMed ID: 29683100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]